Sponsored Resources
IL-31: An important neuroimmune cytokine in prurigo nodularis and atopic dermatitis
December 12th 2023This article is authored by Dr. Baldo Scassellati Sforzolini, M.D., Ph.D., MBA, Global Head of R&D, Galderma and Dr. Christophe Piketty, M.D., Ph.D., Global Senior Program Head at Galderma. IL-31 is a neuroimmune cytokine that drives the most burdensome symptom in prurigo nodularis and atopic dermatitis, namely itch, and is also involved in skin inflammation and keratinocyte abnormalities.
The Benefits of Adding Aesthetic Procedures Into Your Practice
June 25th 2021In the second part of our 3-part recap series of our Roadmap to Recovery webinar, panelists discuss what aesthetic procedures dermatology practices can add to their existing list to increase profit and patient satisfaction.